Ireland· IE-PA-PA2299/019/001
Cernevit, Powder for Solution for Injection or Infusion
A multivitamins, plain product containing retinol palmitate + cholecalciferol + dl-a-tocopherol + ascorbic acid, registered in Ireland by Baxter Holding B.V.. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Retinol palmitate + cholecalciferol + dl-a-tocopherol + ascorbic acid is registered in 4 of 19 countries.
Countries holding a registration under ATC A11BA (multivitamins, plain), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Retinol palmitate + cholecalciferol + dl-a-tocopherol + ascorbic acid · ATC A11BA
4 / 19 countries
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Retinol palmitate + Cholecalciferol + Dl-a-tocopherol + Ascorbic acid
- Manufacturer
- Baxter Holding B.V.
- Country
- Ireland (IE)
- ATC code
- A11BA
- ATC class
- Multivitamins, plain
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2299/019/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A11BA
Multivitamins, plain, as other registers publish it.
- IrelandAbidec Multivitamin Oral Drops SolutionChefaro Ireland DAC
- FinlandCellavieFerrosan A/S
- FinlandGevitalPHARMACIA
- PolandJuvit MultiPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- IrelandKetovite LiquidTaw Pharma (Ireland) Limited
- FinlandLasten Barn Multi-TabsFerrosan A/S
- FinlandMulti-VitanOrion Corporation Orion Pharma
- NorwayMultivitamindroppar unimedicUnimedic
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/04cd2d5c-0efe-4e0f-8b02-5cb3f094030d GET /v1/drugs/04cd2d5c-0efe-4e0f-8b02-5cb3f094030d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for injection/infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"A11BA"
],
"strength": null,
"pa_number": "PA2299/019/001",
"substances": [
"Retinol palmitate",
"Cholecalciferol",
"Dl-a-tocopherol",
"Ascorbic acid",
"Cocarboxylase tetrahydrate",
"Riboflavin sodium phosphate",
"Pyridoxine hydrochloride",
"Cyanocobalamin",
"Folic acid",
"Dexpanthenol",
"D-biotin",
"Nicotinamide"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "04/01/1993",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about retinol palmitate + cholecalciferol + dl-a-tocopherol + ascorbic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.